ADAPTIN BIO, INC.

APTN · OTC · SIC 2836: Biological Products, (No Diagnostic Substances)
21
SEC Filings
$6.27
Close 2026-08-19

Business Summary

Adaptin Bio, Inc. is a biopharmaceutical company developing technology to enhance drug delivery to the brain and other tissues. Its proprietary BRiTE (Brain Bispecific T-cell Engager) platform leverages the immune system to transport therapeutics across the blood-brain barrier. Its lead candidate, APTN-101, is an EGFRvIII-targeting bispecific antibody designed to redirect T cells against glioblastoma and other EGFRvIII-expressing tumors, with an accepted IND for first-in-human clinical trials.

Latest Stock Quote

APTN 2026-08-19 $6.27 O:$6.2666 H:$6.27 L:$6.2666 Vol:0.0M VWAP:$6.2683
origin leaf: null

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-04-012025-12-310001213900-26-038568EDGAR44K words
2025-04-152024-12-310001213900-25-031878EDGAR35K words
2024-04-012023-12-310001213900-24-028681EDGAR19K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001213900-26-089081EDGAR19K words
2025-11-142025-09-300001213900-25-110559EDGAR21K words
2025-08-142025-06-300001213900-25-076361EDGAR18K words
2025-05-152025-03-310001213900-25-044083EDGAR17K words
2024-11-142024-09-300001213900-24-098361EDGAR10K words
2024-08-142024-06-300001213900-24-068816EDGAR9K words
2024-05-152024-03-310001213900-24-043492EDGAR9K words
2023-11-142023-09-300001213900-23-086982EDGAR10K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-250001213900-26-093520EDGAR1K words
2026-04-060001213900-26-040458EDGAR0K words
2025-12-230001213900-25-125451EDGAR1K words
2025-10-060001213900-25-096532EDGAR1K words
2025-04-090001213900-25-030320EDGAR1K words
2025-02-180001213900-25-014630EDGAR8K words

21 total filings indexed. 4 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE ABPO — Abpro Holdings, Inc.

Tags

glioblastoma-/-brain-cancer central-nervous-system-(cns)-disorders autoimmune-disease cardiovascular-disease breast-cancer lung-cancer

Company Identity

CIK0001938571
TickerAPTN
ExchangeOTC
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: e19ce47feaa7dbf2a32a1e79cde799b1769f37458401fba3dc6bef181755b5c1
parent: 694ec791b903229f5ee4720c68b1d80dbd616661c9d3ac5e82ddb3382283579d
content hash: 7019706520a4ad9bf9a759a71f5b17dfc030d513ebcb26fd967e4a43477c0183
signed: 2026-09-29T19:00:18.261Z
sources: 11 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up APTN using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on APTN, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/APTN (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.